Press release
Next Generation Cancer Diagnostic Devices Market Size, Share, Growth and Report 2024-2031
Next Generation Cancer Diagnostic Devices Market || 2024-2031
Cancer diagnostics involves detecting various biomarkers, proteins, and specific symptoms to identify cancerous tumors in patients. This process utilizes specialized technology and devices designed for accurate diagnosis. Cancer diagnosis devices are primarily categorized into several types, including genomics, proteomics, metabolomics, epigenetics, instrument-based methods, and tumor biomarker tests. According to the National Cancer Institute, approximately 2 million cancer cases were diagnosed in the United States in 2018, with nearly 609,640 projected mortality cases due to cancer in the country.
Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/next-generation-cancer-diagnostic-devices-market
Market Dynamics:
The increasing incidence of cancer cases is expected to drive the global next-generation cancer diagnostic device market during the forecast period.
According to the World Health Organization (WHO), cancer is the second leading cause of death globally, with over 18.1 million cases diagnosed in 2018. In the United States, the most common cancers include lung cancer, breast cancer, prostate cancer, colorectal cancer, thyroid cancer, pancreatic cancer, non-Hodgkin lymphoma, melanoma, renal pelvis cancer, kidney cancer, and leukemia. In 2020, WHO reported approximately 19 million new cancer cases worldwide. The American Cancer Society similarly reported 89,500 new cancer cases in the U.S. for 2020. This high incidence of cancer has driven increased adoption of cancer diagnostics devices.
Segment Covered in Next Generation Cancer Diagnostic Devices Market:
By Test Type: Liquid Biopsy, Imaging Tests, Tumour Biomarkers Tests, Insitu Hybridization, Immunohistochemistry, Others.
By Cancer Type: Lung Cancer, Breast Cancer, Prostate Cancer, Blood Cancer, Kidney Cancer, Others.
By End-user: Hospital associated labs, Cancer research institutes, Diagnostic imaging centres, Diagnostic laboratories.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/next-generation-cancer-diagnostic-devices-market
Key players involved in Next Generation Cancer Diagnostic Devices Market:
• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Biocartis
• Becton
• Abbott laboratories
• Hoffman-La Roche AG
• Dickinson and Company
• Thermo Fischer Scientific
• Sysmex Corporation
*Note:
• Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.
Regional Analysis:
The Next Generation Cancer Diagnostic Devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Next Generation Cancer Diagnostic Devices Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Related Reports:
Continuous Passive Movement Market: https://www.datamintelligence.com/research-report/continuous-passive-movement-market
Interventional Radiology Market: https://www.datamintelligence.com/research-report/interventional-radiology-market
Ophthalmic Devices Market: https://www.datamintelligence.com/research-report/ophthalmic-devices-market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next Generation Cancer Diagnostic Devices Market Size, Share, Growth and Report 2024-2031 here
News-ID: 3653029 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
